Products and Services


COREALIS Formulation & Process Development

Source: Ropack, Inc.
Formulation & Process Development by COREALIS Pharma, Inc.
Details

Proof of Concept

  • Feasibility study for the development of a solid dosage form of an active ingredient

Pre-Formulation

  • Compatibility study of the excipients with the active ingredient
  • Characterization of the active ingredient using analytical techniques such as SEM, XRPD, DSC, TGA, NMR, HPLC, and LC-MS, as well as physical testing methodologies such as the determination of particle size, distribution, compressibility, flow, and stability; in order to provide practical insights and quickly optimize the formulation.

Formulation Development

  • Tablets, capsules, and granules
  • New chemical entities, biotechnology products, and controlled substances
  • Immediate or modified release dosage forms
    • Gastric protection
    • Sublingual (orally dissolving tablets)
    • Effervescent
    • Delayed or sustained release
  • Formulation for patent approval
  • Evaluation of formulations
    • Content and weight uniformity
    • Dissolution testing
    • Permeability studies (PAMPA and Caco-2)
    • Stability studies
    • In-vitro bioequivalence studies
    • Flow testing
    • Compression testing
    • Hardness testing
    • Disintegration testing
    • Friability testing
    • Bulk and tap density testing

Process Development

  • Development of the manufacturing process of the product: direct compression, dry or wet granulation, encapsulation, and coating
  • Determination of the critical manufacturing steps and parameters
  • Establishment and justification of the finished product specifications
  • Process implementation justification of the tests and specifications to be respected during production

Most Popular

Need Information?

Please wait... busy